nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—CA9—kidney cancer	0.388	0.526	CbGaD
Diclofenamide—CA2—kidney cancer	0.349	0.473	CbGaD
Diclofenamide—CA2—collecting duct of renal tubule—kidney cancer	0.00832	0.261	CbGeAlD
Diclofenamide—CYP2C9—urine—kidney cancer	0.00251	0.0788	CbGeAlD
Diclofenamide—CA7—renal system—kidney cancer	0.00218	0.0684	CbGeAlD
Diclofenamide—CA7—kidney—kidney cancer	0.00211	0.0661	CbGeAlD
Diclofenamide—CA14—cardiac atrium—kidney cancer	0.00163	0.051	CbGeAlD
Diclofenamide—CA12—renal system—kidney cancer	0.00142	0.0444	CbGeAlD
Diclofenamide—CA12—kidney—kidney cancer	0.00137	0.0429	CbGeAlD
Diclofenamide—Hydrochlorothiazide—KCNMA1—kidney cancer	0.0013	0.192	CrCbGaD
Diclofenamide—CA5B—gonad—kidney cancer	0.00114	0.0357	CbGeAlD
Diclofenamide—CA5B—cardiac atrium—kidney cancer	0.00114	0.0357	CbGeAlD
Diclofenamide—CA1—renal system—kidney cancer	0.00112	0.0352	CbGeAlD
Diclofenamide—CA1—kidney—kidney cancer	0.00108	0.034	CbGeAlD
Diclofenamide—CA4—nephron tubule—kidney cancer	0.000964	0.0302	CbGeAlD
Diclofenamide—Quinethazone—CA2—kidney cancer	0.000926	0.137	CrCbGaD
Diclofenamide—Methyclothiazide—CA2—kidney cancer	0.000888	0.131	CrCbGaD
Diclofenamide—CA4—renal system—kidney cancer	0.000877	0.0275	CbGeAlD
Diclofenamide—Chlorothiazide—CA2—kidney cancer	0.000854	0.126	CrCbGaD
Diclofenamide—CA4—kidney—kidney cancer	0.000847	0.0266	CbGeAlD
Diclofenamide—CA4—cortex of kidney—kidney cancer	0.000825	0.0259	CbGeAlD
Diclofenamide—CA2—nephron tubule—kidney cancer	0.0008	0.0251	CbGeAlD
Diclofenamide—CA4—cardiac atrium—kidney cancer	0.000785	0.0246	CbGeAlD
Diclofenamide—Hydrochlorothiazide—CA9—kidney cancer	0.00078	0.115	CrCbGaD
Diclofenamide—CA2—renal system—kidney cancer	0.000727	0.0228	CbGeAlD
Diclofenamide—CA2—kidney—kidney cancer	0.000703	0.022	CbGeAlD
Diclofenamide—Hydrochlorothiazide—CA2—kidney cancer	0.000702	0.104	CrCbGaD
Diclofenamide—Trichlormethiazide—CA9—kidney cancer	0.000696	0.103	CrCbGaD
Diclofenamide—CA2—cortex of kidney—kidney cancer	0.000684	0.0215	CbGeAlD
Diclofenamide—CA2—cardiac atrium—kidney cancer	0.000651	0.0204	CbGeAlD
Diclofenamide—Trichlormethiazide—CA2—kidney cancer	0.000625	0.0923	CrCbGaD
Diclofenamide—Agranulocytosis—Vinblastine—kidney cancer	0.000625	0.00633	CcSEcCtD
Diclofenamide—Leukopenia—Pazopanib—kidney cancer	0.000591	0.00599	CcSEcCtD
Diclofenamide—Weight decreased—Sorafenib—kidney cancer	0.000588	0.00595	CcSEcCtD
Diclofenamide—Eruption—Doxorubicin—kidney cancer	0.000576	0.00583	CcSEcCtD
Diclofenamide—Ataxia—Vincristine—kidney cancer	0.000575	0.00583	CcSEcCtD
Diclofenamide—Weight decreased—Sunitinib—kidney cancer	0.000565	0.00573	CcSEcCtD
Diclofenamide—Thrombocytopenia—Temsirolimus—kidney cancer	0.00056	0.00567	CcSEcCtD
Diclofenamide—Anorexia—Temsirolimus—kidney cancer	0.000545	0.00552	CcSEcCtD
Diclofenamide—Hypokalaemia—Gemcitabine—kidney cancer	0.000528	0.00535	CcSEcCtD
Diclofenamide—Thrombocytopenia—Pazopanib—kidney cancer	0.000528	0.00535	CcSEcCtD
Diclofenamide—Anorexia—Pazopanib—kidney cancer	0.000514	0.0052	CcSEcCtD
Diclofenamide—Somnolence—Temsirolimus—kidney cancer	0.000509	0.00515	CcSEcCtD
Diclofenamide—Decreased appetite—Temsirolimus—kidney cancer	0.000497	0.00504	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.000494	0.005	CcSEcCtD
Diclofenamide—Fatigue—Temsirolimus—kidney cancer	0.000493	0.005	CcSEcCtD
Diclofenamide—Agranulocytosis—Dactinomycin—kidney cancer	0.000492	0.00499	CcSEcCtD
Diclofenamide—Constipation—Temsirolimus—kidney cancer	0.000489	0.00496	CcSEcCtD
Diclofenamide—Tremor—Everolimus—kidney cancer	0.000488	0.00495	CcSEcCtD
Diclofenamide—Tinnitus—Sorafenib—kidney cancer	0.000485	0.00491	CcSEcCtD
Diclofenamide—Paraesthesia—Pazopanib—kidney cancer	0.000484	0.0049	CcSEcCtD
Diclofenamide—Somnolence—Pazopanib—kidney cancer	0.000479	0.00485	CcSEcCtD
Diclofenamide—Weight decreased—Vincristine—kidney cancer	0.000478	0.00485	CcSEcCtD
Diclofenamide—Dyspepsia—Pazopanib—kidney cancer	0.000474	0.00481	CcSEcCtD
Diclofenamide—Leukopenia—Vinblastine—kidney cancer	0.000468	0.00475	CcSEcCtD
Diclofenamide—Decreased appetite—Pazopanib—kidney cancer	0.000468	0.00475	CcSEcCtD
Diclofenamide—Leukopenia—Everolimus—kidney cancer	0.000467	0.00473	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Pazopanib—kidney cancer	0.000465	0.00471	CcSEcCtD
Diclofenamide—Fatigue—Pazopanib—kidney cancer	0.000465	0.00471	CcSEcCtD
Diclofenamide—Ataxia—Paclitaxel—kidney cancer	0.000457	0.00463	CcSEcCtD
Diclofenamide—Body temperature increased—Temsirolimus—kidney cancer	0.000452	0.00458	CcSEcCtD
Diclofenamide—Hepatic failure—Capecitabine—kidney cancer	0.000444	0.00449	CcSEcCtD
Diclofenamide—Hypokalaemia—Paclitaxel—kidney cancer	0.000442	0.00448	CcSEcCtD
Diclofenamide—Thrombocytopenia—Vinblastine—kidney cancer	0.000418	0.00424	CcSEcCtD
Diclofenamide—Agranulocytosis—Gemcitabine—kidney cancer	0.000417	0.00423	CcSEcCtD
Diclofenamide—Thrombocytopenia—Everolimus—kidney cancer	0.000417	0.00422	CcSEcCtD
Diclofenamide—Asthenia—Temsirolimus—kidney cancer	0.00041	0.00416	CcSEcCtD
Diclofenamide—Anorexia—Vinblastine—kidney cancer	0.000407	0.00413	CcSEcCtD
Diclofenamide—Anorexia—Everolimus—kidney cancer	0.000406	0.00411	CcSEcCtD
Diclofenamide—Leukopenia—Sorafenib—kidney cancer	0.000405	0.0041	CcSEcCtD
Diclofenamide—Pruritus—Temsirolimus—kidney cancer	0.000405	0.0041	CcSEcCtD
Diclofenamide—Thrombocytopenia—Erlotinib—kidney cancer	0.000402	0.00407	CcSEcCtD
Diclofenamide—Anorexia—Erlotinib—kidney cancer	0.000391	0.00396	CcSEcCtD
Diclofenamide—Leukopenia—Sunitinib—kidney cancer	0.00039	0.00395	CcSEcCtD
Diclofenamide—Pollakiuria—Paclitaxel—kidney cancer	0.000388	0.00393	CcSEcCtD
Diclofenamide—Asthenia—Pazopanib—kidney cancer	0.000387	0.00392	CcSEcCtD
Diclofenamide—Paraesthesia—Vinblastine—kidney cancer	0.000384	0.00389	CcSEcCtD
Diclofenamide—Paraesthesia—Everolimus—kidney cancer	0.000382	0.00387	CcSEcCtD
Diclofenamide—Hyperuricaemia—Doxorubicin—kidney cancer	0.000382	0.00387	CcSEcCtD
Diclofenamide—Pruritus—Pazopanib—kidney cancer	0.000381	0.00386	CcSEcCtD
Diclofenamide—Weight decreased—Paclitaxel—kidney cancer	0.00038	0.00385	CcSEcCtD
Diclofenamide—Somnolence—Everolimus—kidney cancer	0.000378	0.00383	CcSEcCtD
Diclofenamide—Dizziness—Temsirolimus—kidney cancer	0.000378	0.00383	CcSEcCtD
Diclofenamide—Ataxia—Capecitabine—kidney cancer	0.000375	0.0038	CcSEcCtD
Diclofenamide—Dyspepsia—Everolimus—kidney cancer	0.000375	0.00379	CcSEcCtD
Diclofenamide—Decreased appetite—Vinblastine—kidney cancer	0.000371	0.00376	CcSEcCtD
Diclofenamide—Decreased appetite—Everolimus—kidney cancer	0.00037	0.00375	CcSEcCtD
Diclofenamide—Leukopenia—Dactinomycin—kidney cancer	0.000369	0.00374	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Everolimus—kidney cancer	0.000367	0.00372	CcSEcCtD
Diclofenamide—Fatigue—Everolimus—kidney cancer	0.000367	0.00372	CcSEcCtD
Diclofenamide—Constipation—Vinblastine—kidney cancer	0.000365	0.0037	CcSEcCtD
Diclofenamide—Constipation—Everolimus—kidney cancer	0.000364	0.00369	CcSEcCtD
Diclofenamide—Vomiting—Temsirolimus—kidney cancer	0.000364	0.00368	CcSEcCtD
Diclofenamide—Hypokalaemia—Capecitabine—kidney cancer	0.000363	0.00368	CcSEcCtD
Diclofenamide—Thrombocytopenia—Sorafenib—kidney cancer	0.000362	0.00366	CcSEcCtD
Diclofenamide—Dyspepsia—Erlotinib—kidney cancer	0.000361	0.00366	CcSEcCtD
Diclofenamide—Rash—Temsirolimus—kidney cancer	0.000361	0.00365	CcSEcCtD
Diclofenamide—Blood uric acid increased—Doxorubicin—kidney cancer	0.00036	0.00365	CcSEcCtD
Diclofenamide—Headache—Temsirolimus—kidney cancer	0.000358	0.00363	CcSEcCtD
Diclofenamide—Decreased appetite—Erlotinib—kidney cancer	0.000357	0.00362	CcSEcCtD
Diclofenamide—Dizziness—Pazopanib—kidney cancer	0.000356	0.00361	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000354	0.00359	CcSEcCtD
Diclofenamide—Fatigue—Erlotinib—kidney cancer	0.000354	0.00359	CcSEcCtD
Diclofenamide—Anorexia—Sorafenib—kidney cancer	0.000352	0.00357	CcSEcCtD
Diclofenamide—Feeling abnormal—Vinblastine—kidney cancer	0.000352	0.00357	CcSEcCtD
Diclofenamide—Constipation—Erlotinib—kidney cancer	0.000351	0.00356	CcSEcCtD
Diclofenamide—Feeling abnormal—Everolimus—kidney cancer	0.000351	0.00355	CcSEcCtD
Diclofenamide—Thrombocytopenia—Sunitinib—kidney cancer	0.000348	0.00353	CcSEcCtD
Diclofenamide—Vomiting—Pazopanib—kidney cancer	0.000343	0.00347	CcSEcCtD
Diclofenamide—Rash—Pazopanib—kidney cancer	0.00034	0.00344	CcSEcCtD
Diclofenamide—Nausea—Temsirolimus—kidney cancer	0.00034	0.00344	CcSEcCtD
Diclofenamide—Anorexia—Sunitinib—kidney cancer	0.000339	0.00343	CcSEcCtD
Diclofenamide—Headache—Pazopanib—kidney cancer	0.000338	0.00342	CcSEcCtD
Diclofenamide—Body temperature increased—Everolimus—kidney cancer	0.000336	0.00341	CcSEcCtD
Diclofenamide—Leukopenia—Vincristine—kidney cancer	0.00033	0.00334	CcSEcCtD
Diclofenamide—Thrombocytopenia—Dactinomycin—kidney cancer	0.000329	0.00334	CcSEcCtD
Diclofenamide—Dyspepsia—Sorafenib—kidney cancer	0.000325	0.00329	CcSEcCtD
Diclofenamide—Body temperature increased—Erlotinib—kidney cancer	0.000325	0.00329	CcSEcCtD
Diclofenamide—Decreased appetite—Sorafenib—kidney cancer	0.000321	0.00325	CcSEcCtD
Diclofenamide—Anorexia—Dactinomycin—kidney cancer	0.000321	0.00325	CcSEcCtD
Diclofenamide—Nausea—Pazopanib—kidney cancer	0.00032	0.00324	CcSEcCtD
Diclofenamide—Paraesthesia—Sunitinib—kidney cancer	0.000319	0.00323	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000319	0.00323	CcSEcCtD
Diclofenamide—Fatigue—Sorafenib—kidney cancer	0.000318	0.00323	CcSEcCtD
Diclofenamide—Constipation—Sorafenib—kidney cancer	0.000316	0.0032	CcSEcCtD
Diclofenamide—Tinnitus—Paclitaxel—kidney cancer	0.000313	0.00317	CcSEcCtD
Diclofenamide—Dyspepsia—Sunitinib—kidney cancer	0.000313	0.00317	CcSEcCtD
Diclofenamide—Leukopenia—Gemcitabine—kidney cancer	0.000313	0.00317	CcSEcCtD
Diclofenamide—Weight decreased—Capecitabine—kidney cancer	0.000312	0.00316	CcSEcCtD
Diclofenamide—Decreased appetite—Sunitinib—kidney cancer	0.000309	0.00313	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000307	0.00311	CcSEcCtD
Diclofenamide—Asthenia—Vinblastine—kidney cancer	0.000306	0.0031	CcSEcCtD
Diclofenamide—Fatigue—Sunitinib—kidney cancer	0.000306	0.0031	CcSEcCtD
Diclofenamide—Asthenia—Everolimus—kidney cancer	0.000305	0.00309	CcSEcCtD
Diclofenamide—Constipation—Sunitinib—kidney cancer	0.000304	0.00308	CcSEcCtD
Diclofenamide—Pruritus—Everolimus—kidney cancer	0.000301	0.00305	CcSEcCtD
Diclofenamide—Asthenia—Erlotinib—kidney cancer	0.000295	0.00298	CcSEcCtD
Diclofenamide—Thrombocytopenia—Vincristine—kidney cancer	0.000294	0.00298	CcSEcCtD
Diclofenamide—Decreased appetite—Dactinomycin—kidney cancer	0.000292	0.00296	CcSEcCtD
Diclofenamide—Body temperature increased—Sorafenib—kidney cancer	0.000292	0.00296	CcSEcCtD
Diclofenamide—Pruritus—Erlotinib—kidney cancer	0.00029	0.00294	CcSEcCtD
Diclofenamide—Fatigue—Dactinomycin—kidney cancer	0.00029	0.00294	CcSEcCtD
Diclofenamide—Tension—Paclitaxel—kidney cancer	0.000287	0.00291	CcSEcCtD
Diclofenamide—Agranulocytosis—Capecitabine—kidney cancer	0.000287	0.0029	CcSEcCtD
Diclofenamide—Anorexia—Vincristine—kidney cancer	0.000287	0.0029	CcSEcCtD
Diclofenamide—Hepatic failure—Doxorubicin—kidney cancer	0.000286	0.0029	CcSEcCtD
Diclofenamide—Nervousness—Paclitaxel—kidney cancer	0.000284	0.00288	CcSEcCtD
Diclofenamide—Dizziness—Vinblastine—kidney cancer	0.000282	0.00286	CcSEcCtD
Diclofenamide—Dizziness—Everolimus—kidney cancer	0.000281	0.00285	CcSEcCtD
Diclofenamide—Body temperature increased—Sunitinib—kidney cancer	0.000281	0.00285	CcSEcCtD
Diclofenamide—Thrombocytopenia—Gemcitabine—kidney cancer	0.000279	0.00283	CcSEcCtD
Diclofenamide—Feeling abnormal—Dactinomycin—kidney cancer	0.000277	0.00281	CcSEcCtD
Diclofenamide—Tremor—Paclitaxel—kidney cancer	0.000274	0.00278	CcSEcCtD
Diclofenamide—Anorexia—Gemcitabine—kidney cancer	0.000272	0.00275	CcSEcCtD
Diclofenamide—Vomiting—Vinblastine—kidney cancer	0.000272	0.00275	CcSEcCtD
Diclofenamide—Dizziness—Erlotinib—kidney cancer	0.000271	0.00275	CcSEcCtD
Diclofenamide—Vomiting—Everolimus—kidney cancer	0.000271	0.00274	CcSEcCtD
Diclofenamide—Paraesthesia—Vincristine—kidney cancer	0.00027	0.00273	CcSEcCtD
Diclofenamide—Rash—Everolimus—kidney cancer	0.000268	0.00272	CcSEcCtD
Diclofenamide—Headache—Vinblastine—kidney cancer	0.000268	0.00271	CcSEcCtD
Diclofenamide—Headache—Everolimus—kidney cancer	0.000267	0.0027	CcSEcCtD
Diclofenamide—Body temperature increased—Dactinomycin—kidney cancer	0.000266	0.00269	CcSEcCtD
Diclofenamide—Asthenia—Sorafenib—kidney cancer	0.000265	0.00268	CcSEcCtD
Diclofenamide—Leukopenia—Paclitaxel—kidney cancer	0.000262	0.00265	CcSEcCtD
Diclofenamide—Decreased appetite—Vincristine—kidney cancer	0.000261	0.00265	CcSEcCtD
Diclofenamide—Pruritus—Sorafenib—kidney cancer	0.000261	0.00265	CcSEcCtD
Diclofenamide—Vomiting—Erlotinib—kidney cancer	0.000261	0.00264	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Vincristine—kidney cancer	0.00026	0.00263	CcSEcCtD
Diclofenamide—Fatigue—Vincristine—kidney cancer	0.000259	0.00263	CcSEcCtD
Diclofenamide—Rash—Erlotinib—kidney cancer	0.000259	0.00262	CcSEcCtD
Diclofenamide—Headache—Erlotinib—kidney cancer	0.000257	0.00261	CcSEcCtD
Diclofenamide—Tinnitus—Capecitabine—kidney cancer	0.000257	0.00261	CcSEcCtD
Diclofenamide—Constipation—Vincristine—kidney cancer	0.000257	0.0026	CcSEcCtD
Diclofenamide—Paraesthesia—Gemcitabine—kidney cancer	0.000256	0.00259	CcSEcCtD
Diclofenamide—Asthenia—Sunitinib—kidney cancer	0.000255	0.00258	CcSEcCtD
Diclofenamide—Nausea—Vinblastine—kidney cancer	0.000254	0.00257	CcSEcCtD
Diclofenamide—Somnolence—Gemcitabine—kidney cancer	0.000254	0.00257	CcSEcCtD
Diclofenamide—Nausea—Everolimus—kidney cancer	0.000253	0.00256	CcSEcCtD
Diclofenamide—Pruritus—Sunitinib—kidney cancer	0.000251	0.00255	CcSEcCtD
Diclofenamide—Decreased appetite—Gemcitabine—kidney cancer	0.000248	0.00251	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000246	0.00249	CcSEcCtD
Diclofenamide—Fatigue—Gemcitabine—kidney cancer	0.000246	0.00249	CcSEcCtD
Diclofenamide—Dizziness—Sorafenib—kidney cancer	0.000244	0.00247	CcSEcCtD
Diclofenamide—Constipation—Gemcitabine—kidney cancer	0.000244	0.00247	CcSEcCtD
Diclofenamide—Nausea—Erlotinib—kidney cancer	0.000244	0.00247	CcSEcCtD
Diclofenamide—Ataxia—Doxorubicin—kidney cancer	0.000242	0.00245	CcSEcCtD
Diclofenamide—Asthenia—Dactinomycin—kidney cancer	0.000241	0.00245	CcSEcCtD
Diclofenamide—Confusional state—Paclitaxel—kidney cancer	0.000241	0.00244	CcSEcCtD
Diclofenamide—Body temperature increased—Vincristine—kidney cancer	0.000238	0.00241	CcSEcCtD
Diclofenamide—Dizziness—Sunitinib—kidney cancer	0.000235	0.00238	CcSEcCtD
Diclofenamide—Feeling abnormal—Gemcitabine—kidney cancer	0.000235	0.00238	CcSEcCtD
Diclofenamide—Vomiting—Sorafenib—kidney cancer	0.000235	0.00238	CcSEcCtD
Diclofenamide—Hypokalaemia—Doxorubicin—kidney cancer	0.000234	0.00237	CcSEcCtD
Diclofenamide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000234	0.00237	CcSEcCtD
Diclofenamide—Rash—Sorafenib—kidney cancer	0.000233	0.00236	CcSEcCtD
Diclofenamide—Headache—Sorafenib—kidney cancer	0.000231	0.00234	CcSEcCtD
Diclofenamide—Anorexia—Paclitaxel—kidney cancer	0.000228	0.00231	CcSEcCtD
Diclofenamide—Vomiting—Sunitinib—kidney cancer	0.000226	0.00229	CcSEcCtD
Diclofenamide—Body temperature increased—Gemcitabine—kidney cancer	0.000225	0.00228	CcSEcCtD
Diclofenamide—Tremor—Capecitabine—kidney cancer	0.000225	0.00228	CcSEcCtD
Diclofenamide—Rash—Sunitinib—kidney cancer	0.000224	0.00227	CcSEcCtD
Diclofenamide—Headache—Sunitinib—kidney cancer	0.000223	0.00226	CcSEcCtD
Diclofenamide—Nausea—Sorafenib—kidney cancer	0.000219	0.00222	CcSEcCtD
Diclofenamide—Asthenia—Vincristine—kidney cancer	0.000216	0.00219	CcSEcCtD
Diclofenamide—Leukopenia—Capecitabine—kidney cancer	0.000215	0.00218	CcSEcCtD
Diclofenamide—Paraesthesia—Paclitaxel—kidney cancer	0.000214	0.00217	CcSEcCtD
Diclofenamide—Vomiting—Dactinomycin—kidney cancer	0.000214	0.00217	CcSEcCtD
Diclofenamide—Somnolence—Paclitaxel—kidney cancer	0.000212	0.00215	CcSEcCtD
Diclofenamide—Rash—Dactinomycin—kidney cancer	0.000212	0.00215	CcSEcCtD
Diclofenamide—Nausea—Sunitinib—kidney cancer	0.000211	0.00214	CcSEcCtD
Diclofenamide—Dyspepsia—Paclitaxel—kidney cancer	0.00021	0.00213	CcSEcCtD
Diclofenamide—Decreased appetite—Paclitaxel—kidney cancer	0.000208	0.0021	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000206	0.00209	CcSEcCtD
Diclofenamide—Fatigue—Paclitaxel—kidney cancer	0.000206	0.00209	CcSEcCtD
Diclofenamide—Pollakiuria—Doxorubicin—kidney cancer	0.000205	0.00208	CcSEcCtD
Diclofenamide—Asthenia—Gemcitabine—kidney cancer	0.000205	0.00207	CcSEcCtD
Diclofenamide—Constipation—Paclitaxel—kidney cancer	0.000204	0.00207	CcSEcCtD
Diclofenamide—Pruritus—Gemcitabine—kidney cancer	0.000202	0.00204	CcSEcCtD
Diclofenamide—Weight decreased—Doxorubicin—kidney cancer	0.000201	0.00204	CcSEcCtD
Diclofenamide—Nausea—Dactinomycin—kidney cancer	0.0002	0.00202	CcSEcCtD
Diclofenamide—Dizziness—Vincristine—kidney cancer	0.000199	0.00201	CcSEcCtD
Diclofenamide—Drowsiness—Doxorubicin—kidney cancer	0.000198	0.00201	CcSEcCtD
Diclofenamide—Confusional state—Capecitabine—kidney cancer	0.000198	0.002	CcSEcCtD
Diclofenamide—Feeling abnormal—Paclitaxel—kidney cancer	0.000197	0.00199	CcSEcCtD
Diclofenamide—Thrombocytopenia—Capecitabine—kidney cancer	0.000192	0.00194	CcSEcCtD
Diclofenamide—Vomiting—Vincristine—kidney cancer	0.000191	0.00194	CcSEcCtD
Diclofenamide—Rash—Vincristine—kidney cancer	0.00019	0.00192	CcSEcCtD
Diclofenamide—Body temperature increased—Paclitaxel—kidney cancer	0.000189	0.00191	CcSEcCtD
Diclofenamide—Headache—Vincristine—kidney cancer	0.000188	0.00191	CcSEcCtD
Diclofenamide—Anorexia—Capecitabine—kidney cancer	0.000187	0.00189	CcSEcCtD
Diclofenamide—Agranulocytosis—Doxorubicin—kidney cancer	0.000185	0.00187	CcSEcCtD
Diclofenamide—Vomiting—Gemcitabine—kidney cancer	0.000181	0.00184	CcSEcCtD
Diclofenamide—Rash—Gemcitabine—kidney cancer	0.00018	0.00182	CcSEcCtD
Diclofenamide—Headache—Gemcitabine—kidney cancer	0.000179	0.00181	CcSEcCtD
Diclofenamide—Nausea—Vincristine—kidney cancer	0.000179	0.00181	CcSEcCtD
Diclofenamide—Paraesthesia—Capecitabine—kidney cancer	0.000176	0.00178	CcSEcCtD
Diclofenamide—Dyspepsia—Capecitabine—kidney cancer	0.000172	0.00175	CcSEcCtD
Diclofenamide—Asthenia—Paclitaxel—kidney cancer	0.000171	0.00174	CcSEcCtD
Diclofenamide—Decreased appetite—Capecitabine—kidney cancer	0.00017	0.00173	CcSEcCtD
Diclofenamide—Nausea—Gemcitabine—kidney cancer	0.000169	0.00172	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000169	0.00171	CcSEcCtD
Diclofenamide—Fatigue—Capecitabine—kidney cancer	0.000169	0.00171	CcSEcCtD
Diclofenamide—Pruritus—Paclitaxel—kidney cancer	0.000169	0.00171	CcSEcCtD
Diclofenamide—Constipation—Capecitabine—kidney cancer	0.000168	0.0017	CcSEcCtD
Diclofenamide—Tinnitus—Doxorubicin—kidney cancer	0.000166	0.00168	CcSEcCtD
Diclofenamide—Feeling abnormal—Capecitabine—kidney cancer	0.000161	0.00164	CcSEcCtD
Diclofenamide—Dizziness—Paclitaxel—kidney cancer	0.000158	0.0016	CcSEcCtD
Diclofenamide—Body temperature increased—Capecitabine—kidney cancer	0.000155	0.00157	CcSEcCtD
Diclofenamide—Tension—Doxorubicin—kidney cancer	0.000152	0.00154	CcSEcCtD
Diclofenamide—Vomiting—Paclitaxel—kidney cancer	0.000152	0.00154	CcSEcCtD
Diclofenamide—Rash—Paclitaxel—kidney cancer	0.000151	0.00153	CcSEcCtD
Diclofenamide—Nervousness—Doxorubicin—kidney cancer	0.00015	0.00152	CcSEcCtD
Diclofenamide—Headache—Paclitaxel—kidney cancer	0.00015	0.00152	CcSEcCtD
Diclofenamide—Nausea—Paclitaxel—kidney cancer	0.000142	0.00144	CcSEcCtD
Diclofenamide—Asthenia—Capecitabine—kidney cancer	0.000141	0.00142	CcSEcCtD
Diclofenamide—Pruritus—Capecitabine—kidney cancer	0.000139	0.0014	CcSEcCtD
Diclofenamide—Leukopenia—Doxorubicin—kidney cancer	0.000139	0.0014	CcSEcCtD
Diclofenamide—Dizziness—Capecitabine—kidney cancer	0.00013	0.00131	CcSEcCtD
Diclofenamide—Confusional state—Doxorubicin—kidney cancer	0.000127	0.00129	CcSEcCtD
Diclofenamide—Vomiting—Capecitabine—kidney cancer	0.000125	0.00126	CcSEcCtD
Diclofenamide—Thrombocytopenia—Doxorubicin—kidney cancer	0.000124	0.00125	CcSEcCtD
Diclofenamide—Rash—Capecitabine—kidney cancer	0.000124	0.00125	CcSEcCtD
Diclofenamide—Headache—Capecitabine—kidney cancer	0.000123	0.00124	CcSEcCtD
Diclofenamide—Anorexia—Doxorubicin—kidney cancer	0.00012	0.00122	CcSEcCtD
Diclofenamide—Nausea—Capecitabine—kidney cancer	0.000116	0.00118	CcSEcCtD
Diclofenamide—Paraesthesia—Doxorubicin—kidney cancer	0.000113	0.00115	CcSEcCtD
Diclofenamide—Somnolence—Doxorubicin—kidney cancer	0.000112	0.00114	CcSEcCtD
Diclofenamide—Dyspepsia—Doxorubicin—kidney cancer	0.000111	0.00113	CcSEcCtD
Diclofenamide—Decreased appetite—Doxorubicin—kidney cancer	0.00011	0.00111	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000109	0.0011	CcSEcCtD
Diclofenamide—Fatigue—Doxorubicin—kidney cancer	0.000109	0.0011	CcSEcCtD
Diclofenamide—Constipation—Doxorubicin—kidney cancer	0.000108	0.00109	CcSEcCtD
Diclofenamide—Feeling abnormal—Doxorubicin—kidney cancer	0.000104	0.00105	CcSEcCtD
Diclofenamide—Body temperature increased—Doxorubicin—kidney cancer	9.98e-05	0.00101	CcSEcCtD
Diclofenamide—Asthenia—Doxorubicin—kidney cancer	9.06e-05	0.000918	CcSEcCtD
Diclofenamide—Pruritus—Doxorubicin—kidney cancer	8.94e-05	0.000905	CcSEcCtD
Diclofenamide—Dizziness—Doxorubicin—kidney cancer	8.35e-05	0.000846	CcSEcCtD
Diclofenamide—Vomiting—Doxorubicin—kidney cancer	8.03e-05	0.000814	CcSEcCtD
Diclofenamide—Rash—Doxorubicin—kidney cancer	7.96e-05	0.000807	CcSEcCtD
Diclofenamide—Headache—Doxorubicin—kidney cancer	7.91e-05	0.000802	CcSEcCtD
Diclofenamide—Nausea—Doxorubicin—kidney cancer	7.5e-05	0.00076	CcSEcCtD
Diclofenamide—CA14—Metabolism—GSTT1—kidney cancer	6.11e-05	0.000489	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—ACHE—kidney cancer	6.11e-05	0.000489	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—ITPR2—kidney cancer	6.09e-05	0.000487	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—ITPR2—kidney cancer	6.09e-05	0.000487	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CA2—kidney cancer	6.07e-05	0.000486	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CRABP1—kidney cancer	6.07e-05	0.000486	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—LDHB—kidney cancer	6.04e-05	0.000483	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—GSTT1—kidney cancer	5.95e-05	0.000476	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—GSTT1—kidney cancer	5.95e-05	0.000476	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—ACHE—kidney cancer	5.95e-05	0.000476	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—ACHE—kidney cancer	5.95e-05	0.000476	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ALAD—kidney cancer	5.92e-05	0.000473	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—SCARB1—kidney cancer	5.78e-05	0.000463	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ST3GAL2—kidney cancer	5.78e-05	0.000462	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PTGS1—kidney cancer	5.72e-05	0.000458	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CA9—kidney cancer	5.69e-05	0.000456	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ALDH1A1—kidney cancer	5.64e-05	0.000452	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—ITPR2—kidney cancer	5.64e-05	0.000452	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—SCARB1—kidney cancer	5.63e-05	0.000451	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—SCARB1—kidney cancer	5.63e-05	0.000451	CbGpPWpGaD
Diclofenamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	5.63e-05	0.00045	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PSMD7—kidney cancer	5.61e-05	0.000449	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PTGS1—kidney cancer	5.58e-05	0.000446	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PTGS1—kidney cancer	5.58e-05	0.000446	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—ACHE—kidney cancer	5.56e-05	0.000445	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—GSTT1—kidney cancer	5.56e-05	0.000445	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—GSTT1—kidney cancer	5.56e-05	0.000445	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—ACHE—kidney cancer	5.56e-05	0.000445	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PSMD7—kidney cancer	5.47e-05	0.000438	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PSMD7—kidney cancer	5.47e-05	0.000438	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CA9—kidney cancer	5.46e-05	0.000437	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PGK1—kidney cancer	5.41e-05	0.000433	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—SLC5A3—kidney cancer	5.41e-05	0.000433	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—BCHE—kidney cancer	5.32e-05	0.000426	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—LDHB—kidney cancer	5.31e-05	0.000425	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—CDKN2A—kidney cancer	5.29e-05	0.000423	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—SCARB1—kidney cancer	5.26e-05	0.000421	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—SCARB1—kidney cancer	5.26e-05	0.000421	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—SLC5A5—kidney cancer	5.26e-05	0.00042	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CA9—kidney cancer	5.23e-05	0.000419	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PTGS1—kidney cancer	5.21e-05	0.000417	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PTGS1—kidney cancer	5.21e-05	0.000417	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—BCHE—kidney cancer	5.18e-05	0.000415	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—BCHE—kidney cancer	5.18e-05	0.000415	CbGpPWpGaD
Diclofenamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.18e-05	0.000414	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GSTT1—kidney cancer	5.15e-05	0.000412	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—ACHE—kidney cancer	5.15e-05	0.000412	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—SLC5A5—kidney cancer	5.12e-05	0.00041	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—SLC5A5—kidney cancer	5.12e-05	0.00041	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PSMD7—kidney cancer	5.11e-05	0.000409	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PSMD7—kidney cancer	5.11e-05	0.000409	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—RELA—kidney cancer	5.09e-05	0.000407	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—SLC2A1—kidney cancer	5.08e-05	0.000406	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—MTOR—kidney cancer	4.99e-05	0.000399	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—GSTT1—kidney cancer	4.95e-05	0.000396	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—SLC2A1—kidney cancer	4.95e-05	0.000396	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—SLC2A1—kidney cancer	4.95e-05	0.000396	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—SCARB1—kidney cancer	4.87e-05	0.00039	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CRABP1—kidney cancer	4.84e-05	0.000387	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—BCHE—kidney cancer	4.84e-05	0.000387	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—BCHE—kidney cancer	4.84e-05	0.000387	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PTGS1—kidney cancer	4.82e-05	0.000386	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—SLC5A5—kidney cancer	4.78e-05	0.000383	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—SLC5A5—kidney cancer	4.78e-05	0.000383	CbGpPWpGaD
Diclofenamide—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	4.78e-05	0.000382	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PSMD7—kidney cancer	4.73e-05	0.000378	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—CDKN1B—kidney cancer	4.68e-05	0.000375	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CRABP1—kidney cancer	4.64e-05	0.000371	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—PTGS1—kidney cancer	4.64e-05	0.000371	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—SLC2A1—kidney cancer	4.62e-05	0.000369	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—SLC2A1—kidney cancer	4.62e-05	0.000369	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ITPR2—kidney cancer	4.5e-05	0.00036	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—BCHE—kidney cancer	4.48e-05	0.000359	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—JUN—kidney cancer	4.46e-05	0.000357	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CRABP1—kidney cancer	4.45e-05	0.000356	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—SLC5A5—kidney cancer	4.43e-05	0.000354	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ITPR2—kidney cancer	4.32e-05	0.000345	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—SLC2A1—kidney cancer	4.28e-05	0.000342	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—GSTP1—kidney cancer	4.23e-05	0.000339	CbGpPWpGaD
Diclofenamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.2e-05	0.000336	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ITPR2—kidney cancer	4.14e-05	0.000331	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—GSTP1—kidney cancer	4.13e-05	0.00033	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—GSTP1—kidney cancer	4.13e-05	0.00033	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ACHE—kidney cancer	4.1e-05	0.000328	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GSTT1—kidney cancer	4.1e-05	0.000328	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	4.09e-05	0.000327	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—ABCB1—kidney cancer	4.01e-05	0.000321	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GSTT1—kidney cancer	3.94e-05	0.000315	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ACHE—kidney cancer	3.94e-05	0.000315	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CRABP1—kidney cancer	3.91e-05	0.000313	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—ABCB1—kidney cancer	3.91e-05	0.000312	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—ABCB1—kidney cancer	3.91e-05	0.000312	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—VEGFA—kidney cancer	3.89e-05	0.000312	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—GSTM1—kidney cancer	3.89e-05	0.000311	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—SCARB1—kidney cancer	3.89e-05	0.000311	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—GSTP1—kidney cancer	3.85e-05	0.000308	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—GSTP1—kidney cancer	3.85e-05	0.000308	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PTGS1—kidney cancer	3.85e-05	0.000308	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—GSTM1—kidney cancer	3.79e-05	0.000303	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—GSTM1—kidney cancer	3.79e-05	0.000303	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTT1—kidney cancer	3.77e-05	0.000302	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ACHE—kidney cancer	3.77e-05	0.000302	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PSMD7—kidney cancer	3.77e-05	0.000302	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—SCARB1—kidney cancer	3.73e-05	0.000298	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—CYP1A1—kidney cancer	3.69e-05	0.000295	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PTGS1—kidney cancer	3.69e-05	0.000295	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—MAPK3—kidney cancer	3.68e-05	0.000295	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—ABCB1—kidney cancer	3.65e-05	0.000292	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—ABCB1—kidney cancer	3.65e-05	0.000292	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ITPR2—kidney cancer	3.64e-05	0.000291	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PSMD7—kidney cancer	3.62e-05	0.000289	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—CYP1A1—kidney cancer	3.59e-05	0.000288	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—CYP1A1—kidney cancer	3.59e-05	0.000288	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—BCHE—kidney cancer	3.58e-05	0.000286	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—SCARB1—kidney cancer	3.57e-05	0.000286	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GSTP1—kidney cancer	3.57e-05	0.000285	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—GSTM1—kidney cancer	3.54e-05	0.000283	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—GSTM1—kidney cancer	3.54e-05	0.000283	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PTGS1—kidney cancer	3.54e-05	0.000283	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—SLC5A5—kidney cancer	3.53e-05	0.000283	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—MAPK1—kidney cancer	3.51e-05	0.00028	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PSMD7—kidney cancer	3.47e-05	0.000277	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—GSTP1—kidney cancer	3.43e-05	0.000275	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—BCHE—kidney cancer	3.43e-05	0.000274	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—SLC2A1—kidney cancer	3.41e-05	0.000273	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—SLC5A5—kidney cancer	3.39e-05	0.000271	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	3.38e-05	0.000271	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—ABCB1—kidney cancer	3.38e-05	0.00027	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—CYP1A1—kidney cancer	3.36e-05	0.000268	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—CYP1A1—kidney cancer	3.36e-05	0.000268	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ACHE—kidney cancer	3.32e-05	0.000265	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTT1—kidney cancer	3.32e-05	0.000265	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—BCHE—kidney cancer	3.29e-05	0.000263	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GSTM1—kidney cancer	3.28e-05	0.000262	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—SLC2A1—kidney cancer	3.27e-05	0.000262	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—SLC5A5—kidney cancer	3.25e-05	0.00026	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—GSTM1—kidney cancer	3.15e-05	0.000252	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—SCARB1—kidney cancer	3.14e-05	0.000251	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—SLC2A1—kidney cancer	3.14e-05	0.000251	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	3.11e-05	0.000249	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PTGS1—kidney cancer	3.11e-05	0.000249	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CYP1A1—kidney cancer	3.11e-05	0.000249	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PSMD7—kidney cancer	3.05e-05	0.000244	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	2.99e-05	0.000239	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	2.95e-05	0.000236	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—TP53—kidney cancer	2.94e-05	0.000235	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—BCHE—kidney cancer	2.89e-05	0.000231	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—SLC5A5—kidney cancer	2.85e-05	0.000228	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GSTP1—kidney cancer	2.85e-05	0.000228	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—SLC2A1—kidney cancer	2.76e-05	0.000221	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—POMC—kidney cancer	2.75e-05	0.00022	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GSTP1—kidney cancer	2.73e-05	0.000218	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ABCB1—kidney cancer	2.69e-05	0.000215	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—POMC—kidney cancer	2.68e-05	0.000214	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—POMC—kidney cancer	2.68e-05	0.000214	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ACY1—kidney cancer	2.63e-05	0.00021	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTP1—kidney cancer	2.62e-05	0.000209	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GSTM1—kidney cancer	2.61e-05	0.000209	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ABCB1—kidney cancer	2.58e-05	0.000207	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GSTM1—kidney cancer	2.51e-05	0.000201	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—POMC—kidney cancer	2.5e-05	0.0002	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—POMC—kidney cancer	2.5e-05	0.0002	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CYP1A1—kidney cancer	2.48e-05	0.000198	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ABCB1—kidney cancer	2.48e-05	0.000198	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTM1—kidney cancer	2.4e-05	0.000192	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CYP1A1—kidney cancer	2.38e-05	0.00019	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—POMC—kidney cancer	2.32e-05	0.000185	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTP1—kidney cancer	2.3e-05	0.000184	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CYP1A1—kidney cancer	2.28e-05	0.000182	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.24e-05	0.000179	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PDHB—kidney cancer	2.24e-05	0.000179	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—POMC—kidney cancer	2.23e-05	0.000178	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PTGS2—kidney cancer	2.19e-05	0.000175	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ABCB1—kidney cancer	2.18e-05	0.000174	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PTGS2—kidney cancer	2.14e-05	0.000171	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PTGS2—kidney cancer	2.14e-05	0.000171	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTM1—kidney cancer	2.11e-05	0.000169	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CCBL1—kidney cancer	2.1e-05	0.000168	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CYP1A1—kidney cancer	2e-05	0.00016	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PTGS2—kidney cancer	2e-05	0.00016	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PTGS2—kidney cancer	2e-05	0.00016	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PTEN—kidney cancer	1.91e-05	0.000153	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.9e-05	0.000152	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PTEN—kidney cancer	1.86e-05	0.000149	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PTEN—kidney cancer	1.86e-05	0.000149	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PTGS2—kidney cancer	1.85e-05	0.000148	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—POMC—kidney cancer	1.85e-05	0.000148	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.82e-05	0.000146	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PPAT—kidney cancer	1.82e-05	0.000146	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.8e-05	0.000144	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.78e-05	0.000143	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—POMC—kidney cancer	1.77e-05	0.000142	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PTEN—kidney cancer	1.74e-05	0.000139	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PTEN—kidney cancer	1.74e-05	0.000139	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—POMC—kidney cancer	1.7e-05	0.000136	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—APRT—kidney cancer	1.69e-05	0.000136	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—FH—kidney cancer	1.69e-05	0.000136	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.66e-05	0.000133	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PTEN—kidney cancer	1.61e-05	0.000129	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GPC3—kidney cancer	1.59e-05	0.000127	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CA2—kidney cancer	1.55e-05	0.000124	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALAD—kidney cancer	1.51e-05	0.000121	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—POMC—kidney cancer	1.49e-05	0.000119	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.47e-05	0.000118	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PTGS2—kidney cancer	1.47e-05	0.000118	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.44e-05	0.000115	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PTGS2—kidney cancer	1.41e-05	0.000113	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PGK1—kidney cancer	1.38e-05	0.000111	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.38e-05	0.000111	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PTGS2—kidney cancer	1.35e-05	0.000108	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—LDHB—kidney cancer	1.35e-05	0.000108	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—PIK3CA—kidney cancer	1.35e-05	0.000108	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—PIK3CA—kidney cancer	1.31e-05	0.000105	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—PIK3CA—kidney cancer	1.31e-05	0.000105	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PTEN—kidney cancer	1.29e-05	0.000103	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PTEN—kidney cancer	1.23e-05	9.86e-05	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—PIK3CA—kidney cancer	1.23e-05	9.82e-05	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—PIK3CA—kidney cancer	1.23e-05	9.82e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PTGS2—kidney cancer	1.19e-05	9.53e-05	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PTEN—kidney cancer	1.18e-05	9.45e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CA9—kidney cancer	1.17e-05	9.4e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.15e-05	9.19e-05	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—PIK3CA—kidney cancer	1.14e-05	9.1e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PTEN—kidney cancer	1.04e-05	8.31e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CRABP1—kidney cancer	9.99e-06	7.99e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ITPR2—kidney cancer	9.28e-06	7.43e-05	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—PIK3CA—kidney cancer	9.07e-06	7.26e-05	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—PIK3CA—kidney cancer	8.69e-06	6.96e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.56e-06	6.85e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTT1—kidney cancer	8.47e-06	6.77e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ACHE—kidney cancer	8.47e-06	6.77e-05	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—PIK3CA—kidney cancer	8.34e-06	6.67e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SCARB1—kidney cancer	8.01e-06	6.41e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PTGS1—kidney cancer	7.93e-06	6.35e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PSMD7—kidney cancer	7.78e-06	6.23e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—BCHE—kidney cancer	7.38e-06	5.9e-05	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—PIK3CA—kidney cancer	7.33e-06	5.86e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC5A5—kidney cancer	7.29e-06	5.83e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC2A1—kidney cancer	7.04e-06	5.63e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.83e-06	5.46e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.95e-06	4.76e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTP1—kidney cancer	5.87e-06	4.7e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ABCB1—kidney cancer	5.56e-06	4.44e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTM1—kidney cancer	5.39e-06	4.32e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP1A1—kidney cancer	5.11e-06	4.09e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.2e-06	3.36e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—POMC—kidney cancer	3.81e-06	3.05e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PTGS2—kidney cancer	3.04e-06	2.43e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PTEN—kidney cancer	2.65e-06	2.12e-05	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.87e-06	1.5e-05	CbGpPWpGaD
